Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomas.

R M Sharkey; D M Goldenberg; R Vagg; D Pawlyk; G Y Wong; J A Siegel; S Murthy; G M Levine; D Izon; P Gascon

doi:10.1002/1097-0142(19940201)73:3+<864::aid-cncr2820731318>3.0.co;2-9

Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomas.

Identifier:nobleid.org/w1/20260515/AF830758

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AF830758.svg?ark=w1%2F20260515%2FAF830758)](https://nobleid.org/work/w1/20260515/AF830758)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomas.

Identifier:nobleid.org/w1/20260515/AF830758

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AF830758.svg?ark=w1%2F20260515%2FAF830758)](https://nobleid.org/work/w1/20260515/AF830758)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work